Classic pilocytic astrocytoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:673580
Who is this for?
Show terms as
1Active trials3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗NORD ↗

FDA & Trial Timeline

2 events
Aug 2019Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

St. Jude Children's Research Hospital — NA

TrialRECRUITING
Jul 2010Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

National Cancer Institute (NCI) — PHASE1

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Classic pilocytic astrocytoma.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
N/A
Actively Recruiting
PI: Thomas Merchant, MD (St. Jude Children's Research Hospital) · Sites: Rochester, Minnesota; Memphis, Tennessee · Age: 621 yrs

Specialists

3 foundView all specialists →
JF
Jason R Fangusaro
Los Angeles, California
Specialist

Rare Disease Specialist

PI on 3 active trials3 Classic pilocytic astrocytoma publications
SM
Scot C. Remick, MD
SCARBOROUGH, ME
Specialist
PI on 9 active trials
EM
Edward G. Shaw, MD
Specialist
PI on 4 active trials

Treatment Centers

8 centers
⚗️ Trial Site

National Institutes of Health Clinical Center

📍 Bethesda, Maryland

👤 Payal P Khincha, M.D.

👤 Christopher Grunseich, M.D.

⚗️ Trial Site

Children's Hospital Colorado

📍 Aurora, Colorado

👤 Zachary Grinspan, MD

⚗️ Trial Site

Children's National Medical Center

📍 Washington D.C., District of Columbia

👤 Richard Neibeger, MD

⚗️ Trial Site

Cincinnati Children's Hospital Medical Center

📍 Cincinnati, Ohio

⚗️ Trial Site

Duke University Medical Center

📍 Durham, North Carolina

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

Travel Grants

No travel grants are currently matched to Classic pilocytic astrocytoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Classic pilocytic astrocytomaForum →

No community posts yet. Be the first to share your experience with Classic pilocytic astrocytoma.

Start the conversation →

Latest news about Classic pilocytic astrocytoma

Disease timeline:

New recruiting trial: Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

A new clinical trial is recruiting patients for Classic pilocytic astrocytoma

New trial: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

Phase PHASE1 trial recruiting. Biospecimen Collection

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Classic pilocytic astrocytoma

Are there clinical trials for Classic pilocytic astrocytoma?

Yes — 1 recruiting clinical trial is currently listed for Classic pilocytic astrocytoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Classic pilocytic astrocytoma?

3 specialists and care centers treating Classic pilocytic astrocytoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.